SEARCH

SEARCH BY CITATION

REFERENCES

  • Agarwal, R., E.E. Medrano, I.U. Khan, J.J. Nordlund, and H. Mukhtar (1991) Metabolism of benzo(a)pyrene by human melanocytes in culture. Carcinogenesis, 12, 19631966.
  • Albert, D.M., C.A. Puliafito, A.B. Fulton, N.L. Robinson, Z.N. Zakov, T.P. Dryja, A.B. Smith, E. Egan, and S.S. Leffingwell (1980) Increased incidence of choroidal malignant melanoma occurring in a single population of chemical workers. A.J. Ophthalmol., 89, 323337.
  • Anders, A., H. Gröger, F. Anders, C. Zechel, and A. Smith (1991) Discrimination of initiating and promoting carcinogens in fish. Ann. Rech. Vet., 22, 273294.
  • Austin, D.F. and P. Reynolds (1986) Occupation and malignant melanoma of the skin. Recent Results Cane. Res., 102, 98107.
  • Barbeau, A., L. Dallaire, N.T. Buu, J. Poirier, and E. Rucinska (1985) Comparative behavioral biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens. Life Sci., 37, 15291538.
  • Barden, H. and S. Levin (1983) Histochemical observations on rodent brain melanin. Brain Res. Bull., 10, 847851.
  • Barthel, E. (1985) Erhöhte Mortalität an Ösophaguskrebs, Magenkrebs und Hautmelanom bei Pestizid-exponierten Schädlingsbekämpfern in der DDR. Arch. Geschwulstforsch., 55, 481488.
  • Bergman, K. (1985) Autoradiographic distribution of 14C-labeled 3H-imidazo(4,5-f)quinoline-2-amines in mice. Cancer Res., 45, 13511356.
  • Berkelhammer, J., R.W. Oxenhandler, R.R. Hook, and J.M. Hennessy (1982) Development of a new melanoma model in C57BL/6 mice. Cancer Res., 42, 31573163.
  • Borg, K. and H. Tjälve (1988) Effect of thiram and dithiocarbamate pesticides on the gastrointestinal absorption and distribution of nickel in mice. Toxicol. Lett., 42, 8798.
  • Brandt, I., J.-Å. Gustafsson, and J. Rafter (1983) Distribution of the carcinogenic tryptophan pyrolysis product Trp-P-1 in control, 9-hydroxyellipticine and beta-naphtoflavone pretreated mice. Carcinogenesis, 4, 12911296.
  • Brandt, I., B. Kowalski, J.-Å. Gustafsson, and J. Rafter (1989) Tissue localization of the carcinogenic glutamic acid pyrolysis product GLU-P-1 in control and beta-naphtoflavone-treated mice and rats. Carcinogenesis, 10, 15291533.
  • Burns, R.P. (1966) Delayed onset of chloroquine retinopathy. New Engl. J. Med., 275, 693696.
  • Carlsson, A. (1970) Biochemical aspects of abnormal movements induced by L-dopa. In: L-Dopa and parkinsonism. A.Barbeau and F.H.McDowell eds. F.A. Davis Co., Philadelphia , pp. 205213.
  • Chiba, K., A. Trevor, and N. Castagnoli Jr. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun., 120, 574578.
  • Chiueh, C.C., S.P. Markey, R.S. Burns, J. Johannessen, D.M. Jacobowitz, and I.J. Kopin (1983) N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine, a parkinsonian syndrome causing agent in man and monkey, produces different effects in guinea pig and rat. Pharmacologist, 25, 131.
  • Christensen, E., J.E. Möller, and A. Faurbye (1970) Neuropathological investigation of 28 brains from patients with dyskinesia. Acta Psychiatr. Scand., 46, 1423.
  • D'Amato, R.J., Z.P. Lipman, and S.H. Snyder (1986) Selectivity of the parkinsonian neurotoxin MPTP: Toxic metabolite MPP + binds to neuromelanin. Science, 231, 987989.
  • Danielsson, B.R.G., A. Oskarsson, and L. Dencker (1984) Placental transfer and fetal distribution of lead in mice after treatment with dithiocarbamates. Arch. Toxicol., 55, 2733.
  • Dencker, L., N.G. Lindquist, and S. Ullberg (1973) Mechanism of drug-induced chronic otic lesions. Role of drug accumulation on the melanin of the inner ear. Experientia, 29, 13621363.
  • Dencker, L. and N.G. Lindquist (1975) Distribution of labeled chloroquine in the inner ear. Arch. Otolaryngol., 101, 185188.
  • Dencker, L., B. Larsson, K. Olander, S. Ullberg, and M. Yokota (1979) False precursors of melanin as selective melanoma seekers. Br. J. Cancer, 39, 449452.
  • Dencker, L., B. Larsson, K. Olander, S. Ullberg, and M. Yokota (1981) Incorporation of thiouracil and some related compounds into growing melanin. Acta Pharmacol. Toxicol., 49, 141149.
  • Evans, R.D., A.W. Kopf, R.A. Lew, D.S. Rigel, R.S. Bart, R.J. Friedman, and J.K. Rivers (1988) Risk factors for the development of malignant melanoma.-I: Review of case-control studies. J. Dermatol. Surg. Oncol., 14, 393408.
  • Felix, C.C., J.S. Hyde, T. Sarna and R.C. Sealy (1978) Interactions of melanin with metal ions: Electron spin resonance evidence for chelate complexes of metal ions with free radicals. J. Am. Chem. Soc., 100, 39223926.
  • Goerttler, K., H. Loehrke, J. Schweizer, and B. Hesse (1980) Two-stage tumorigenesis of dermal melanocytes in the back skin of the Syrian golden hamster using systemic initiation with 7,12-dimethyl-benz(a)anthracene and topical promotion with 12-o-tetradecanoyl-phorbol-13-acetate. Cancer Res., 40, 155161.
  • Goodman, L.S. and A.G. Gilman (1985) The pharmacological basis of therapeutics. Seventh edition. A.G.Gilman, L.S.Goodman, T.W.Rall, and F.Murad eds. MacMillan Publishing Company, New York , 1839 pages.
  • Greiner, A.C. and K. Berry (1964) Skin pigmentation and corneal and lens opacities with prolonged chlorpromazine therapy. Canad. Med. Ass. J., 90, 663665.
  • Gupta, S.K., R.C. Murthy, and S.V. Chandra (1980) Neuromelanin in manganese-exposed primates. Toxicol. Lett., 6, 1720.
  • Hallman, H., L. Olson, and G. Jonsson (1984) Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. Eur. J. Pharmacol., 97, 133136.
  • Hartvig, P., N.G. Lindquist, S.M. Aquilonius, R. D'Argy, K. Bergström, U. Bondesson, S.Å. Eckernäs, P. Gullberg, B.S. Larsson, B. Lindberg, H. Lundqvist, A. Lydén, B. Långstrom, P. Malmborg K. Någren, and C.-G. Stålnacke (1986) Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by positron emission tomography and whole body autoradiography. Life Sci., 38, 8997.
  • Heikkila, R.E., A. Hess, and R.C. Duvoisin (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science, 224, 14511453.
  • Heldaas, S.S., A. A. Andersen, and S. Langård (1987) Incidence of cancer among vinyl chloride and polyvinyl chloride workers: Further evidence for an association with malignant melanoma. Br. J. Ind. Med., 44, 278280.
  • Homewood, C.A., D.C. Warhurst, W. Peters, and V.C. Baggaley (1972) Lysosomes, pH, and the antimalarial action of chloroquine. Nature (London), 235, 5052.
  • Ito, S. (1986) Reexamination of the structure of eumelanin. Biochim. Biophys. Acte, 883, 155161.
  • Jasim, S. and H. Tjälve (1986) Effect of sodium pyridinethione on the uptake and distribution of nickel, cadmium and zink in pregnant and non-pregnant mice. Toxicology, 38, 327350.
  • Koh, H.K., B.E. Kliger, and R.A. Lew (1990) Sunlight and cutaneous malignant melanoma: Evidence for and against causation. Photochem. Photobiol., 51, 765779.
  • Langston, J.W., I. Irwin, E.B. Langston, and L.S. Forno (1984) 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett., 48, 8792.
  • Larsson, B., A. Oskarsson, and H. Tjälve (1977) Binding of paraquat and diquat on melanin. Exp. Eye Res., 25, 353359.
  • Larsson B. and H. Tjälve (1978) Studies on the melanin affinity of metal ions. Acta Physiol. Scand., 104, 479484.
  • Larsson, B. (1979) Mechanisms of accumulation of foreign substances in melanin. Binding to preformed melanin and incorporation into growing melanin. Acta Universitatis Upsaliensis, 43, 152.
  • Larsson, B. and H. Tjälve (1979) Studies on the mechanism of drug-binding to melanin. Biochem. Pharmacol., 28, 11811187.
  • Larsson, B., M. Nilsson, and H. Tjälve (1981) The tissue-disposition of gentamicin in rats. Acta Pharmacol. Toxicol., 48, 269278.
  • Larsson, B., K. Olander, L. Dencker, and L. Holmqvist (1982) Accumulation of 125I-labelled thiouracil and propylthiouracil in murine melanotic melanomas. Br. J. Cancer, 46, 538550.
  • Larsson, P., B.S. Larsson, and H. Tjälve (1988) Binding of aflatoxin B1 to melanin. Fd. Chem. Toxic., 26, 579586.
  • Larsson, B.S., H. Tjälve, P. Larsson, A. Roberto, I. Brandt, and K. Bergman (1989) Retention of carcinogens in pigmented tissues due to melanin affinity. Abstract (2nd Meeting of the ESPCR, Uppsala, Sweden, 1989). ESPCR Bulletin (Special Issue):43.
  • Larsson, B.S. (1991) Melanin-affinic thioureas as selective melanoma seekers. Melanoma Res., 1, 8590.
  • Larsson, B.S., N.G. Lindquist, E. Johansson, and T. Liljefors (1991) Analysis of metals in skin melanin. Abstract. 3rd Annual Meeting of the ESPCR, Amsterdam 1991, p. 62.
  • Lindquist, N.G. and S. Ullberg (1972) The melanin affinity of chloroquine and chlorpromazine studied by whole body autoradiography. Acta Pharmacol. Toxicol., 31, (Suppl. 2):132.
  • Lindquist, N.G. (1973) Accumulation of drugs on melanin. Acta Radiol. (Diagn.) (Stockh.), (Suppl. 325):192.
  • Lindquist, N.G., A. Lydén-Sokolowski, and B.S. Larsson (1986) Accumulation of a parkinsonism-inducing neurotoxin in melanin-bearing neurons: Autoradiographic studies on 3H-MPTP. Acta Pharmacol. Toxicol., 59, 161164.
  • Lindquist, N.G., B.S. Larsson, and A. Lydén-Sokolowski (1987) Neuromelanin and its possible protective and destructive properties. Pigment Cell Res., 1, 133136.
  • Lindquist, N.G., B.S. Larsson, and A. Lydén-Sokolowski (1988) Autoradiography of (14C)paraquat or (14C)diquat in frogs and mice: Accumulation in neuromelanin. Neurosci. Lett., 93, 16.
  • Lydén, A., U. Bondesson, B.S. Larsson, and N.G. Lindquist (1983) Melanin affinity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, an inducer of chronic parkinsonism in humans. Acta Pharmacol. Toxicol., 53, 429432.
  • Lydén, A., B.S. Larsson, and N.G. Lindquist (1984) Melanin affinity of manganese. Acta Pharmacol. Toxicol., 55, 133138.
  • Lydén-Sokolowski, A., B.S. Larsson, and N.G. Lindquist (1988) Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition. Pharmacol. Toxicol., 63, 7580.
  • Lydén-Sokolowski, A. (1990) Melanin binding of MPTP and related substances, and manganese: Possible connection with parkinsonism. Acta Universitatis Upsaliensis, 63, 152.
  • Lyttkens, L., B. Larsson, and S.-A. Wasterström (1984) Local anaesthetics and tinnitus. Proposed peripheral mechanism of action of lidocaine. ORL, 46, 1723.
  • MacKie, R.M. and T. Aitchison (1982) Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br. J. Cancer. 46, 955960.
  • Magnani, C., D. Coggon, C. Osmond, and E.D. Acheson (1987) Occupation and five cancers: A case-control study using death certificates. Br. J. Ind. Med., 44, 769776.
  • Markey, S.P., N.J. Johannessen, C.C. Chiueh, R.S. Burns, and M.A. Herkenham (1984) Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature, 311, 464467.
  • Marsden, C.D. (1969) Brain melanin. In: Pigments in pathology. M.Wollman, ed. Academic Press, New York , pp. 395420.
  • Mena, I., O. Marin, S. Fuenzalida, and G.C. Cotzias (1967) Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology, 17, 128136.
  • Meyer zum Gottesberge-Orsulakova, A. (1985) Pigment und Ionen-transport im Vestibularorgan. Laryng. Rhinol. Otol., 64, 364367.
  • Olander, K., B. Larsson, and I. Dencker (1983) Thioamides as false melanin precursors: Studies in murine melanomas. Acta Pharmacol. Toxicol., 52, 135142.
  • Palumbo, A., M. D'Ischia, G. Misuraca, A. Iannone, and G. Prota (1990) Selective uptake of 2-thiouracil into melanin-producing systems depends on chemical binding to enzymically generated dopaquinone. Biochim. Biophys. Acte, 1036, 221227.
  • Pannatier, A., P. Jenner, B. Teste, and C. Etter (1978) The skin as a drug-metabolizing organ. Drug Metab. Rev., 8, 319343.
  • Pell, S., M.T. O'Berg, and B.W. Karrh (1978) Cancer epidemiologic surveillance in the DuPont Company. J. Occup. Med., 20, 725740.
  • Potts, A.M. (1962) The concentration of phenothiazines in the eye of experimental animals. Invest. Ophthalmol. Vis. Sci., 1, 522530.
  • Potts, A.M. (1964) The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Ophthalmol. Vis. Sci., 3, 405416.
  • Prota, G. (1992) Melanins and melanogenesis. Academic Press, New York , 290 pages.
  • Raghavan, P.R., P.A. Zane, and S.L. Tripp (1990) Calculation of drug-melanin binding energy using molecular modeling. Experientia, 46, 7780.
  • Ramsay, R.R., J.I. Salach, and T.P. Singer (1986) Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+. Biochem. Biophys. Res. Commun., 134, 743748.
  • Richardson, M.A. and T.J. Craig (1982) The coexistence of parkinsonism-like symptoms and tardive dyskinesia. Am. J. Psychiatry, 139, 341343.
  • Rodier, J. (1955) Manganese poisoning in Moroccan miners. Brit. J. Ind. Med., 12, 2135.
  • Roskoski Jr., R. and S.R. Jaskunas (1972) Chloroquine and primaquine inhibition of rat liver cell-free polynudeotide-dependent polypeptide synthesis. Biochem. Pharmacol., 21, 391399.
  • Schmidt, W.R. and L.W. Jarcho (1966) Persistent dyskinesias following phenothiazine therapy. Arch. Neurol., 14, 369377.
  • Stepien, K.B. and T. Wilczok (1982) Studies of the mechanism of chloroquine binding to synthetic dopa-melanin. Biochem. Pharmacol., 31, 33593365.
  • Swartz, H.M., T. Sarna, and L. Zecca (1992) Modulation by neuromelanin of the availability and reactivity of metal ions. Ann. Neurol., 32, S69S75.
  • Tammela, M. (1985) Tissue localization of some organic and inorganic cations. Binding to melanin and cartilage. Acte Universitatis Upsaliensis, 111, 142.
  • Thomas, T.L. and P. Decoufle (1979) Mortality among workers employed in the pharmaceutical industry: A preliminary investigation. J. Occup. Med., 21, 619623.
  • Tjälve, H., M. Nilsson, and B. Larsson (1981) Binding of 14C-spermidine to melanin in vivo and in vitro. Acte Physiol. Scand., 112, 209214.
  • Tjälve, H., M. Nilsson, and B. Larsson (1982) Thallium-201: Autoradiography in pigmented mice and melanin-binding in vitro. Acte Pharmacol. Toxicol., 51, 147153.
  • Whittaker, J.R. (1966) Anomalous differentiation of melanin granules caused by thiouracil. Exp. Cell Res., 44, 351361.